Bio-Sep: Funding, Investors & Team (Oct 2026)
Biorefinery innovation to isolate non-food squander lignocellulosic biomass into high-esteem biochemicals
Bio-Sep has raised $1.7M across 1 funding round on record, the most recent a Seed of $1.7M announced in Jun 2022.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Bio-Sep Company Profile and Key Stats
Latest funding round on record: Jun 2022.
Bio-Sep Funding Rounds
Bio-Sep Founders and Leadership Team
Contact details for the Bio-Sep team: 1 of 1 has an email address on file.
Start 14-day free trial →Bio-Sep Funding Compared to Other Biotechnology Startups
Bio-Sep's latest round of $1.7M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Bio-Sep in Biotechnology and Wooburn
Companies Similar to Bio-Sep
R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…
The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…
Argonaute RNA company research projects build on existing intellectual property.
An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…
ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
Bio-Sep Funding FAQs
What does Bio-Sep do?
Biorefinery innovation to isolate non-food squander lignocellulosic biomass into high-esteem biochemicals
How much funding has Bio-Sep raised?
Bio-Sep has raised $1.7M across 1 round on record. The most recent is a Seed of $1.7M announced in Jun 2022.
When did Bio-Sep last raise funding?
Bio-Sep's most recent funding round on record is a Seed of $1.7M, announced in Jun 2022.
Who is the CEO of Bio-Sep?
Adrian Black is listed as CEO at Bio-Sep.
Where is Bio-Sep headquartered?
Bio-Sep is based in Wooburn, Buckinghamshire, United Kingdom.
How many employees does Bio-Sep have?
Bio-Sep is in the 1-10 employee band.
How does Bio-Sep's funding compare to other Biotechnology startups?
Bio-Sep's latest round of $1.7M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Bio-Sep Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Bio-Sep is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.